UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004616
Receipt No. R000005493
Scientific Title A randomized phase ll study comparing neoadjuvant FAP and DCF for the resectable advanced esophageal cancer (OGSG 1003)
Date of disclosure of the study information 2010/12/01
Last modified on 2020/01/05 17:29:33

No. Disposal Last modified on Item of update
1 Insert 2010/11/24 19:24:03
2 Update 2011/03/02 17:40:03 Key inclusion criteria
Key inclusion criteria
3 Update 2011/11/22 19:00:27 Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/11/22 19:14:16 Anticipated trial start date
Last follow-up date
5 Update 2012/06/24 22:58:02 Public title
Public title
Acronym
Acronym
6 Update 2012/06/24 23:01:38 Organization
Organization
Division name
Division name
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Email1
7 Update 2012/12/25 22:07:32 Recruitment status
8 Update 2013/05/24 21:34:31 Anticipated trial start date
Last follow-up date
9 Update 2014/07/27 22:45:24 Date analysis concluded
10 Update 2015/05/28 22:40:32 Last follow-up date
Publication of results
Results
Results
11 Update 2015/05/28 22:50:56 Email
Email
Email
Institutions
12 Update 2015/05/28 23:05:12 Results
Results
13 Update 2015/05/28 23:18:00 Institutions
14 Update 2016/10/23 19:30:32 Organization
Name of primary sponsor
Organization
15 Update 2016/12/01 12:49:37 Interventions/Control_1
Key inclusion criteria
16 Update 2017/12/10 21:52:07 Recruitment status
Publication of results
URL related to results and publications
Results
Results
17 Update 2018/04/30 23:18:46 Email
Email
18 Update 2018/04/30 23:23:11 Results
Results
19 Update 2018/05/10 20:25:36 Email
Email
20 Update 2020/01/05 14:29:25 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
21 Update 2020/01/05 17:29:33 Results
Results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Outcome measures
Outcome measures


Contact us.